Author: Mike Rosenbluth

Swing in the News

This week, Swing Therapeutics received De Novo marketing authorization by the U.S. Food and Drug Administration (FDA) for Stanza, the…

Press Releases

Today marks an important milestone at Swing Therapeutics: Stanza, the first prescription digital therapy for fibromyalgia patients, is now commercially…